Neuphoria Therapeutics Inc
NEUP
$3.71+0.27%
Delayed · as of Sep 22, 2026, 10:31 AM ET
Mkt cap
$23.56M
EV/Sales
3.15
P/E ratio
N/A
FY2026 Revenue
$1.17M
EPS (9mo ended 2026-03-31)
$-2.00
Gross Margin (FY2026)
N/A
Profit Margin (FY2026)
-1145.66%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported NEUP revenue for 2026-06-30 was $1.2M. Net income was -$13.5M. Revenue was down 92.5% from 2025-06-30 to 2026-06-30. NEUP currently screens at market cap $23.6M.
Use this NEUP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NEUP income, balance, and cash tables.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company in the Healthcare sector.
Latest cached Neuphoria Therapeutics Inc (NEUP) revenue for Jun 30, 2026 was $1.2M. Net income was -$13.5M. Statements: https://lician.com/financials/neup
Neuphoria Therapeutics Inc (NEUP) market capitalization is $23.6M on the latest cached snapshot.
Neuphoria Therapeutics Inc (NEUP) cached previous close $3.70; day range $3.69 – $3.79; volume 17,845. Session quote: https://lician.com/quote/neup
Neuphoria Therapeutics Inc (NEUP) latest cached earnings event is "NEUP earnings" on Oct 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NEUP filing is 8-K · Jul 24, 2026. Filings: https://lician.com/sec/neup